Peppermint

This is peppermint’s best-evidenced use. Enteric-coated or sustained-release peppermint oil capsules (typically 180–225 mg two to three times daily, delivering roughly 0.2–0.4 mL oil per dose) reduce global IBS symptoms and abdominal pain versus placebo across numerous double-blind trials ^{6,7,8,9Reference 6Cappello et al. · 2007RCTPeppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial — randomised controlled trialView study →Reference 7Merat et al. · 2010RCTThe effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome — randomised controlled trialView study →Reference 8Cash et al. · 2016RCTA novel delivery system of peppermint oil is an effective therapy for irritable bowel syndrome symptoms — randomised controlled trialView study →Reference 9Liu et al. · 1997RCTEnteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome — randomised controlled trialView study →}. Several meta-analyses pool this into a consistent benefit: a 2008 BMJ review found peppermint oil superior to placebo for global symptoms ^{2Reference 2Ford et al. · 2008Meta-analysisEffect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome — systematic review, meta-analysisView study →}, and later syntheses by Khanna (2014), Alammar (2019) and Ingrosso (2022) reached the same conclusion, with numbers-needed-to-treat in the low single digits for symptom response ^{1,3,4Reference 1Ingrosso et al. · 2022Meta-analysisSystematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome — systematic review, meta-analysisView study →Reference 3Khanna et al. · 2014Meta-analysisPeppermint oil for the treatment of irritable bowel syndrome — systematic review, meta-analysisView study →Reference 4Alammar et al. · 2019Meta-analysisThe impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data — meta-analysisView study →}. The largest recent phase III RCT (Weerts 2020, n=190) confirmed reduced abdominal pain even though it missed the strict FDA composite responder endpoint, illustrating that effect size is modest and endpoint-sensitive ^{5Reference 5Weerts et al. · 2020RCTEfficacy and safety of peppermint oil in a randomized, double-blind trial of patients with irritable bowel syndrome — randomised controlled trialView study →}. Mechanism is antispasmodic: menthol blocks L-type calcium channels in intestinal smooth muscle, relaxing it ^{21,22Reference 21Hills et al. · 1991In vitroThe mechanism of action of peppermint oil on gastrointestinal smooth muscleView study →Reference 22Hawthorn et al. · 1988In vitroThe actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations — in vitroView study →}. The effect is specific to the standardised oil in a formulation that survives the stomach — it does not extend to peppermint tea. A paediatric RCT (Kline 2001) reported similar symptom relief in children with IBS ^{20Reference 20Kline et al. · 2001RCTEnteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children — randomised controlled trialView study →}, and a controlled study reported peppermint oil shifts the gut microbiome in children with functional abdominal pain ^{30Reference 30Thapa et al. · 2022Peppermint oil effects on the gut microbiome in children with functional abdominal pain — controlled studyView study →}.

Gap: trials are heterogeneous in formulation, dose and duration, follow-up is usually short (2–12 weeks), and long-term efficacy and relapse rates are largely untested.

Peppermint oil is effective here almost entirely as half of a fixed combination with caraway oil (marketed as Menthacarin/Enteroplant), not on its own. Randomised, placebo-controlled trials show the combination relieves epigastric pain, fullness and cramping in functional dyspepsia and improves quality of life ^{11,13Reference 11May et al. · 2000RCTEfficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia — randomised controlled trialView study →Reference 13Rich et al. · 2017RCTA randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia — randomised controlled trialView study →}, with an active-comparator trial reporting efficacy comparable to cisapride ^{12Reference 12Holtmann et al. · 2003RCTEffects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia — randomised controlled trialView study →}. A 2019 systematic review and meta-analysis of the peppermint–caraway combination confirmed a significant symptom benefit over placebo ^{14Reference 14Li et al. · 2019Meta-analysisA combination of peppermint oil and caraway oil for the treatment of functional dyspepsia: a systematic review and meta-analysis — systematic review, meta-analysisView study →}. The plausible mechanism combines menthol-driven smooth-muscle relaxation with caraway’s carminative action, plus possible visceral-sensitivity and gastric-accommodation effects ^{10Reference 10Chumpitazi et al. · 2018ReviewReview article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders — reviewView study →}.

Gap: the evidence is for the peppermint + caraway combination — it cannot be assumed to hold for peppermint oil alone, and the trials are dominated by a single proprietary preparation.

Applied directly to the gut lumen (sprayed intraluminally or given as capsules before the procedure), dilute peppermint oil relaxes smooth muscle and reduces spasm during endoscopy. A clinical trial found intraluminal peppermint oil an effective antispasmodic during ERCP ^{15Reference 15Yamamoto et al. · 2006Clinical trialEfficacy of peppermint oil as an antispasmodic during endoscopic retrograde cholangiopancreatography — clinical trialView study →}, and randomised trials plus a 2020 systematic review and meta-analysis report that peppermint oil eases colonic spasm, improves caecal-intubation conditions and reduces spasm scores during colonoscopy ^{16Reference 16Aziz et al. · 2020Meta-analysisThe anti-spasmodic effect of peppermint oil during colonoscopy: a systematic review and meta-analysis — systematic review, meta-analysisView study →}, with a double-blind RCT of pre-procedure capsules showing similar benefit ^{17Reference 17Shavakhi et al. · 2012RCTPremedication with peppermint oil capsules in colonoscopy: a double blind placebo-controlled randomized trial study — randomised controlled trialView study →}. This is a direct, topical antispasmodic use — the same menthol calcium-channel mechanism as in IBS, applied acutely rather than therapeutically over weeks.

Gap: trials use varied delivery (intraluminal spray vs oral capsule) and endpoints (spasm score, intubation time, patient comfort), and it is a procedural aid, not a treatment.

Applied topically, a 10% peppermint oil solution in ethanol dabbed on the forehead and temples eased tension-type headache in small double-blind trials from the Göbel group, with pain relief reported as comparable to paracetamol at 15–30 minutes ^{18,19Reference 18Göbel et al. · 1996RCTEffectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type — randomised controlled trialView study →Reference 19Göbel et al. · 2016ReviewPeppermint oil in the acute treatment of tension-type headache — reviewView study →}. The proposed mechanism is menthol activating cold-sensitive TRPM8 receptors in the skin, producing analgesia and muscle relaxation rather than any systemic action ^{19Reference 19Göbel et al. · 2016ReviewPeppermint oil in the acute treatment of tension-type headache — reviewView study →}.

Gap: the human evidence is a small number of older trials from essentially one research group, with no large independent replication; the effect is for topical oil, not oral or tea use.

Peppermint’s water-soluble phenolics — chiefly rosmarinic acid and related polyphenols — are strong radical scavengers in vitro, quenching DPPH and hydrogen peroxide in aqueous leaf extracts ^{23Reference 23Sroka et al. · 2005In vitroAntiradical and anti-H2O2 properties of polyphenolic compounds from an aqueous peppermint extract — in vitroView study →}. In mice, a leaf extract showed radioprotective, antioxidant activity against gamma irradiation, raising endogenous antioxidant enzymes ^{24Reference 24Samarth et al. · 2006AnimalRadioprotective influence of Mentha piperita (Linn) against gamma irradiation in mice: antioxidant and radical scavenging activity — animal modelView study →}. These findings are consistent with the leaf’s phenolic content but stop at biochemical and animal endpoints.

Gap: no human study links peppermint intake to a meaningful antioxidant clinical outcome; the activity is measured in test tubes and rodents at doses unrelated to normal use.

Peppermint aromatherapy (inhaled oil) is widely used for nausea, and a 2024 systematic review and meta-analysis of aromatherapy for cancer-related nausea found a modest benefit across pooled RCTs ^{25Reference 25Ahn et al. · 2024Meta-analysisEffects of aromatherapy on nausea and vomiting in patients with cancer: a systematic review and meta-analysis of randomized controlled trials — systematic review, meta-analysisView study →}, with a paediatric randomised trial reporting reduced chemotherapy nausea from a peppermint–lemon blend ^{26Reference 26Şancı et al. · 2023RCTEffect of peppermint-lemon aromatherapy on nausea-vomiting and quality of life in pediatric patients with leukemia: a randomized controlled trial — randomised controlled trialView study →}. Results are inconsistent, though, and many trials combine peppermint with other oils or use it as adjunct to antiemetics, making the specific contribution of peppermint hard to isolate.

Gap: trials are small and heterogeneous, frequently use blended oils, and blinding of an aromatic intervention is inherently weak — the signal is suggestive, not established.

Peppermint essential oil and its main volatiles inhibit a range of bacteria, fungi and biofilms in vitro. Studies report antibacterial, antifungal and anti-biofilm activity for the oil, including inhibition of Candida albicans and Listeria biofilms ^{27Reference 27Saharkhiz et al. · 2012In vitroChemical composition, antifungal and antibiofilm activities of the essential oil of Mentha piperita L. — in vitroView study →}. The activity tracks the menthol and menthone content and reflects membrane-disrupting action of the monoterpenes.

Gap: all data are in vitro, at oil concentrations far above what any oral or topical human use delivers — there is no clinical antimicrobial evidence, and this does not support treating infection.

In animal models, aqueous peppermint leaf extract produced antinociception (reduced acetic-acid writhing in mice) without a measurable anti-oedema effect, suggesting an analgesic mechanism separate from anti-inflammatory action ^{28Reference 28Taher · 2012AnimalAntinociceptive activity of Mentha piperita leaf aqueous extract in mice — animal modelView study →}. Related preclinical work reports modest systemic anti-inflammatory activity for peppermint extracts ^{28Reference 28Taher · 2012AnimalAntinociceptive activity of Mentha piperita leaf aqueous extract in mice — animal modelView study →}. The topical cooling analgesia seen with the oil is again attributable to menthol acting on TRPM8 sensory receptors.

Gap: evidence is animal and in vitro only, the antinociceptive and anti-inflammatory signals are dissociated, and there is no controlled human trial of peppermint for pain or inflammation apart from topical headache use.

Peppermint is well tolerated as a food and in the doses used therapeutically, and it is one of the better-studied herbs for safety ^{10Reference 10Chumpitazi et al. · 2018ReviewReview article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders — reviewView study →}. The most common adverse effect of the oil is heartburn: menthol relaxes the lower oesophageal sphincter, so peppermint can aggravate gastro-oesophageal reflux and should be used cautiously, or in enteric-coated form, by people with reflux or hiatus hernia ^{10Reference 10Chumpitazi et al. · 2018ReviewReview article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders — reviewView study →}. Enteric coating largely shifts release past the stomach and reduces this effect ^{5,10Reference 5Weerts et al. · 2020RCTEfficacy and safety of peppermint oil in a randomized, double-blind trial of patients with irritable bowel syndrome — randomised controlled trialView study →Reference 10Chumpitazi et al. · 2018ReviewReview article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders — reviewView study →}. Rare allergic and contact reactions to menthol occur, and the astringent tannins in the leaf can modestly reduce iron absorption, so leaf preparations are best taken apart from iron-rich meals or supplements. Peppermint oil should not be applied to the face or chest of infants and young children because menthol can trigger reflex apnoea.

Two of the oil’s minor monoterpenes, pulegone and menthofuran, are hepatotoxic, which is why the European Pharmacopoeia caps them (pulegone ≤4%, menthofuran 1–9%); this is the rationale for avoiding prolonged high-dose therapeutic oil use. Drug interactions are only partly assessed: reflux aggravation and the tannin/iron-absorption effect are documented, and reviews raise a theoretical menthol–CYP interaction, but no clinically significant drug interaction is well established and no dedicated interaction trials exist ^{10Reference 10Chumpitazi et al. · 2018ReviewReview article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders — reviewView study →}.